{"id":419323,"date":"2019-08-14T05:34:01","date_gmt":"2019-08-14T05:34:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=419323"},"modified":"2019-08-14T05:34:01","modified_gmt":"2019-08-14T05:34:01","slug":"fondaparinux-market-to-show-tremendous-growth-due-to-increasing-number-of-hip-knee-surgeries-and-rising-heart-infections-diseases-till-2024-million-insights","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/fondaparinux-market-to-show-tremendous-growth-due-to-increasing-number-of-hip-knee-surgeries-and-rising-heart-infections-diseases-till-2024-million-insights_419323.html","title":{"rendered":"Fondaparinux Market To Show Tremendous Growth Due To Increasing Number of Hip & Knee Surgeries And Rising Heart Infections Diseases Till 2024 | Million Insights"},"content":{"rendered":"
\"Fondaparinux<\/a><\/p>\n
\n
Million Insights – World’s Fastest Growing Market Research Database<\/div>\n<\/div>\n<\/div>\n
According to new report available with Million Insights, the global fondaparinux industry is predicted to grow at a CAGR of 7.8% in the forecast period, providing numerous opportunities for market players to invest in research and development of the market.<\/div>\n

Global Fondaparinux Market<\/a> is expected to reach USD 686.3 billion by 2024. Fondaparinux is also termed as Fondaparinux sodium or Natural heparin pentasaccharide is an anticoagulant medication chemically related to low molecular weight heparins. Its trade name is Arixtra. Its molecular formula is C31H53N3O49S8 and molecular weight is 1508.217 g\/mol. Factor Xa inhibits its activity and interrupts the blood coagulation cascade by stopping thrombus development and thrombin formation. It is a synthetic glucopyranoside with antithrombotic activity. The Fondaparinux Market is estimated to grow at a significant CAGR of 7.8% over the forecast period as the scope and its applications are rising enormously across the globe.<\/p>\n

Growing number of hip and knee surgeries, mounting cooperation between major players for securing the intellectual property rights (IPRs), growing aging population and diseases like orthopedic conditions and heart infections are documented as major factors of Fondaparinux Market that are estimated to enhance the growth in the years to come. However, severe side effects of drugs may restrain overall market in the coming years. Fondaparinux Market is segmented based on product type, application, end user, and region.<\/p>\n

Full Research Report On Global <\/strong>Fondaparinux Market<\/strong> Analysis available at:<\/strong> https:\/\/www.millioninsights.com\/industry-reports\/fondaparinux-market<\/a><\/p>\n

Generics drug and branded drug are the product types that could be explored in Fondaparinux during the forecast period. The market may be categorized based on applications like abdominal surgery, orthopedics (knee or hip replacement), cardiovascular, and others that could be explored in the forecast period. Home care settings, clinics, ambulatory surgical centers, hospitals, diagnostic centers, and other end users could be explored in Fondaparinux during the forecast period.<\/p>\n

Globally, North America accounted for the substantial market share of Fondaparinux and is estimated to lead the overall market in the coming years. The reason behind the overall market growth could be presence of key manufacturers in the region, growing awareness among populace regarding brand and upcoming drugs, and technological enhancements as growing aging population. The United States is a major consumer of Fondaparinux in this region.<\/p>\n

Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The aspects that may be ascribed to the growth comprise growing awareness among patients and healthcare sectors and developing industries in this region. The developing countries like India and China are the major consumers of Fondaparinux in this region.<\/p>\n

The key players of Fondaparinux industry are Kaifeng Pharmaceutical, Pfizer, Inc., WisMed Pharmaceuticals, Bayer Healthcare AG, Eisai Inc., GlaxoSmithKline Plc., Bristol-Myers Squibb Company, BoehringerIngelheim, Aspen Holdings, Sanofi S.A., Abbott India Limited, and Apotex. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As companies all over the world have to believe that alliance with a market would permit them proportional market existence and authority to declare the leadership position.<\/p>\n

Request for Free Sample Copy at:<\/strong> https:\/\/www.millioninsights.com\/industry-reports\/fondaparinux-market\/request-sample<\/a><\/p>\n

Market Segment:<\/strong><\/p>\n

Fondaparinux market, product outlook by revenue (USD Million, 2011 – 2024)<\/strong>
    • Branded
    • Generics<\/p>\n

Fondaparinux market, product outlook by volume (thousand units, 2011 – 2024)<\/strong>
    • Branded
    • Generics<\/p>\n

Fondaparinux market, regional outlook by revenue (USD Million, 2011 – 2024)<\/strong>
    • North America
    • Europe
    • Asia Pacific
    • China
    • RoW<\/p>\n

Fondaparinux market, regional outlook by volume (thousand units, 2011 – 2024)<\/strong>
    • North America
    • Europe
    • Asia Pacific
    • China
    • RoW<\/p>\n

Related Reports of this Category available at Million Insights:<\/strong> https:\/\/www.millioninsights.com\/industry\/healthcare<\/a><\/p>\n

About Million Insights
<\/strong>Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.<\/p>\n

For More Information:<\/strong> www.millioninsights.com<\/a><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Million Insights<\/a>
Contact Person:<\/strong> Ryan Manuel
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 91-20-65300184
Address:<\/strong>Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.millioninsights.com\/industry-reports\/fondaparinux-market<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Million Insights – World’s Fastest Growing Market Research Database According to new report available with Million Insights, the global fondaparinux industry is predicted to grow at a CAGR of 7.8% in the forecast period, providing numerous opportunities for market players … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,410,406,416],"tags":[],"class_list":["post-419323","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Manufacturing-Industry","category-Pharmaceuticals-Biotech","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/419323","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=419323"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/419323\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=419323"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=419323"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=419323"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}